Austrália - inglês - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - hydrochlorothiazide, quantity: 12.5 mg; telmisartan, quantity: 40 mg - tablet, multilayer - excipient ingredients: sodium starch glycollate type a; meglumine; lactose monohydrate; sodium hydroxide; maize starch; microcrystalline cellulose; mannitol; magnesium stearate; povidone; iron oxide red - telmisartan hct mylan is indicated for the treatment of hypertension. treatment should not be initiated with these combinations.

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - hydrochlorothiazide, quantity: 25 mg; telmisartan, quantity: 80 mg - tablet, multilayer - excipient ingredients: microcrystalline cellulose; sodium hydroxide; maize starch; magnesium stearate; povidone; sodium starch glycollate type a; lactose monohydrate; meglumine; mannitol; iron oxide yellow - telmisartan hct mylan is indicated for the treatment of hypertension. treatment should not be initiated with these combinations.

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - hydrochlorothiazide, quantity: 12.5 mg; telmisartan, quantity: 80 mg - tablet, multilayer - excipient ingredients: lactose monohydrate; mannitol; maize starch; sodium starch glycollate type a; povidone; magnesium stearate; sodium hydroxide; meglumine; microcrystalline cellulose; iron oxide red - telmisartan hct mylan is indicated for the treatment of hypertension. treatment should not be initiated with these combinations.

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - sildenafil citrate, quantity: 70.24 mg (equivalent: sildenafil, qty 50 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; croscarmellose sodium; macrogol 8000; hyprolose; titanium dioxide; magnesium stearate; colloidal anhydrous silica; hypromellose - sildenafil is indicated for the treatment of erectile dysfunction in adult males. sildenafil is not indicated for use by women.

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - sildenafil citrate, quantity: 70.24 mg (equivalent: sildenafil, qty 50 mg) - tablet, film coated - excipient ingredients: colloidal anhydrous silica; magnesium stearate; hyprolose; macrogol 8000; hypromellose; croscarmellose sodium; microcrystalline cellulose; titanium dioxide - sildenafil is indicated for the treatment of erectile dysfunction in adult males. sildenafil is not indicated for use by women.

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - sildenafil citrate, quantity: 35.12 mg (equivalent: sildenafil, qty 25 mg) - tablet, film coated - excipient ingredients: hypromellose; croscarmellose sodium; titanium dioxide; macrogol 8000; magnesium stearate; hyprolose; colloidal anhydrous silica; microcrystalline cellulose - sildenafil is indicated for the treatment of erectile dysfunction in adult males. sildenafil is not indicated for use by women.

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - sildenafil citrate, quantity: 35.12 mg (equivalent: sildenafil, qty 25 mg) - tablet, film coated - excipient ingredients: titanium dioxide; hyprolose; colloidal anhydrous silica; croscarmellose sodium; microcrystalline cellulose; macrogol 8000; magnesium stearate; hypromellose - sildenafil is indicated for the treatment of erectile dysfunction in adult males. sildenafil is not indicated for use by women.

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - sildenafil citrate, quantity: 140.48 mg (equivalent: sildenafil, qty 100 mg) - tablet, film coated - excipient ingredients: macrogol 8000; titanium dioxide; hyprolose; hypromellose; magnesium stearate; microcrystalline cellulose; colloidal anhydrous silica; croscarmellose sodium - sildenafil is indicated for the treatment of erectile dysfunction in adult males. sildenafil is not indicated for use by women.

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - sildenafil citrate, quantity: 35.121 mg (equivalent: sildenafil, qty 25 mg) - tablet, film coated - excipient ingredients: purified water; croscarmellose sodium; calcium hydrogen phosphate; magnesium stearate; microcrystalline cellulose; titanium dioxide; hypromellose; triacetin; indigo carmine aluminium lake - vedafil is indicated for the treatment of erectile dysfunction in adult males. . vedafil is not indicated for use by women.

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - sildenafil citrate, quantity: 140.483 mg (equivalent: sildenafil, qty 100 mg) - tablet, film coated - excipient ingredients: magnesium stearate; croscarmellose sodium; calcium hydrogen phosphate; microcrystalline cellulose; purified water; titanium dioxide; hypromellose; triacetin; indigo carmine aluminium lake - vedafil is indicated for the treatment of erectile dysfunction in adult males. . vedafil is not indicated for use by women.